GLP-1 Agonists (e.g., Ozempic) provide significant blood sugar control and weight loss, ideal for patients prioritizing weight management
Some studies suggest that it could be responsible for causing an L-Carnitine deficiency as it promotes the absorption of other forms
Lactobacillus and Bifidobacterium , for instance, help balance the gut microbiome, which influences GLP-1 production through fermentation of fibers into SCFAs
Overall, AST demonstrates considerable potential as a neuroprotective agent in AD
This dosing convenience, combined with robust weight loss and cardiovascular benefits, expands the addressable patient pool beyond diabetes to include obesity, heart disease, and metabolic disorders
(2) BPC-157 appears to have a particular antidepressant activity, which may counteract serotonin-induced action